Yukiko Arisaka

18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

Kotaro Higashi, Yoshimichi Ueda, Yukiko Arisaka et al. · PubMed · 2002 · 275 citations

Medicine, Oncology, Chemotherapy +16

Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 191 citations

Medicine, Nuclear Medicine, Oncology +15

FDG PET measurement of the proliferative potential of non-small cell lung cancer.

Kotaro Higashi, Yoshimichi Ueda, Mizuki Yagishita et al. · PubMed · 2000 · 173 citations

Medicine, Nuclear Medicine, Oncology +17

The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT

Koichi Okamura, Yukio Yonemoto, Yukiko Arisaka et al. · Lara D. Veeken · 2012 · 67 citations · Full text

Medicine, Clinical Sciences, Nuclear Medicine +15

Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy

Akie Takano, Noboru Oriuchi, Yoshito Tsushima et al. · Annals of Nuclear Medicine · 2008 · 56 citations

Medicine, Oncology, Radiology +17